MII Implementation Guide Microbiology
2027.0.0-ballot2 -
Germany
MII Implementation Guide Microbiology - Local Development build (v2027.0.0-ballot2) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Active as of 2023-03-02 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="mii-vs-mikrobio-voraussichtliche-empfindlichkeit"/>
<language value="en"/>
<text>
<status value="extensions"/>
<div xml:lang="en" lang="en"><hr/><p><b>English</b></p><hr/><p class="res-header-id"><b>Generated Narrative: ValueSet mii-vs-mikrobio-voraussichtliche-empfindlichkeit</b></p><a name="mii-vs-mikrobio-voraussichtliche-empfindlichkeit"> </a><a name="hcmii-vs-mikrobio-voraussichtliche-empfindlichkeit"> </a><ul><li>Include these codes as defined in <a href="http://terminology.hl7.org/7.2.0/CodeSystem-v3-ObservationInterpretation.html"><code>http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation</code></a><span title="Version is explicitly stated to be 4.0.0"> version 📍4.0.0</span><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href="http://terminology.hl7.org/7.2.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-S">S</a></td><td>Susceptible</td><td>Bacterial strain inhibited by in vitro concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic success. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized\_Terminolo.htm) Synonym (earlier term): Sensitive Projects: ISO 20776-1, ISO 20776-2<br/><br/>\[Note 1: Bacterial strains are categorized as susceptible by applying the appropriate breakpoints in a defined phenotypic system.\]<br/><br/>\[Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).\]</td></tr><tr><td><a href="http://terminology.hl7.org/7.2.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-I">I</a></td><td>Intermediate</td><td>Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with uncertain therapeutic effect. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized\_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2<br/><br/>\[Note 1: Bacterial strains are categorized as intermediate by applying the appropriate breakpoints in a defined phenotypic test system.\]<br/><br/>\[Note 2: This class of susceptibility implies that an infection due to the isolate can be appropriately treated in body sites where the drugs are physiologically concentrated or when a high dosage of drug can be used.\]<br/><br/>\[Note 3: This class also indicates a "buffer zone," to prevent small, uncontrolled, technical factors from causing major discrepancies in interpretations.\]<br/><br/>\[Note 4: These breakpoints can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).\]</td></tr><tr><td><a href="http://terminology.hl7.org/7.2.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-R">R</a></td><td>Resistant</td><td>Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic failure. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized\_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2<br/><br/>\[Note 1: Bacterial strains are categorized as resistant by applying the appropriate breakpoints in a defined phenotypic test system.\]<br/><br/>\[Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).\]</td></tr></table></li></ul></div>
</text>
<url
value="https://www.medizininformatik-initiative.de/fhir/modul-mikrobio/ValueSet/mii-vs-mikrobio-voraussichtliche-empfindlichkeit"/>
<version value="2027.0.0-ballot2"/>
<name value="MII_VS_Mikrobio_Voraussichtliche_Empfindlichkeit"/>
<title value="MII VS Mikrobio Voraussichtliche Empfindlichkeit"/>
<status value="active"/>
<experimental value="false"/>
<date value="2023-03-02T00:00:00Z"/>
<publisher value="Medizininformatik Initiative"/>
<contact>
<name value="Medizininformatik Initiative"/>
<telecom>
<system value="url"/>
<value value="https://www.medizininformatik-initiative.de"/>
</telecom>
</contact>
<description
value="Ergebnis-ValueSet für die voraussichtliche Empfindlichkeit: die aus genotypischen Nachweisen abgeleitete erwartete Kategorie sensibel, intermediär oder resistent."/>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="DE"/>
<display value="Germany"/>
</coding>
</jurisdiction>
<compose>
<include>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"/>
<version value="4.0.0"/>
<concept>
<code value="S"/>
<display value="Susceptible"/>
</concept>
<concept>
<code value="I"/>
<display value="Intermediate"/>
</concept>
<concept>
<code value="R"/>
<display value="Resistant"/>
</concept>
</include>
</compose>
</ValueSet>